Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial

This article was originally published in The Tan Sheet

Executive Summary

J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.


Related Content

In Most Consumers' OTC Pain Relief Decisions, Safety Missing As A Factor
J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge
Judge Slams J&J Spin On Study Suggesting Acetaminophen-Induced Liver Damage
OTC Acetaminophen Label Guidance For Liver Warning Clarifies Ingredient Specifics
Tylenol Extra Strength Liver Damage Litigation Fails On ‘Ambiguity’ Of Use
McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst